Literature DB >> 20133500

IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?

Marianne Labussiere1, Marc Sanson, Ahmed Idbaih, Jean-Yves Delattre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20133500      PMCID： PMC3227941          DOI： 10.1634/theoncologist.2009-0218

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  25 in total

1.  Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells.

Authors:  Su Min Lee; Ho-Jin Koh; Dong-Chan Park; Byoung J Song; Tae-Lin Huh; Jeen-Woo Park
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

Review 2.  Cancer cell killing via ROS: to increase or decrease, that is the question.

Authors:  Jie Wang; Jing Yi
Journal:  Cancer Biol Ther       Date:  2008-12-24       Impact factor: 4.742

3.  Analysis of the IDH1 codon 132 mutation in brain tumors.

Authors:  Jörg Balss; Jochen Meyer; Wolf Mueller; Andrey Korshunov; Christian Hartmann; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2008-11-05       Impact factor: 17.088

4.  D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats.

Authors:  Alexandra Latini; Karina Scussiato; Rafael Borba Rosa; Susana Llesuy; Adriane Belló-Klein; Carlos Severo Dutra-Filho; Moacir Wajner
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

Review 5.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.

Authors:  Masuko Ushio-Fukai; Yoshimasa Nakamura
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

Review 6.  Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review.

Authors:  Mahdi Aghili; Fatemeh Zahedi; Elham Rafiee
Journal:  J Neurooncol       Date:  2008-10-18       Impact factor: 4.130

7.  IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.

Authors:  Fonnet E Bleeker; Simona Lamba; Sieger Leenstra; Dirk Troost; Theo Hulsebos; W Peter Vandertop; Milo Frattini; Francesca Molinari; Margaret Knowles; Aniello Cerrato; Monica Rodolfo; Aldo Scarpa; Lara Felicioni; Fiamma Buttitta; Sara Malatesta; Antonio Marchetti; Alberto Bardelli
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Allosteric motions in structures of yeast NAD+-specific isocitrate dehydrogenase.

Authors:  Alexander B Taylor; Gang Hu; P John Hart; Lee McAlister-Henn
Journal:  J Biol Chem       Date:  2008-02-06       Impact factor: 5.157

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079
View more
  26 in total

1.  Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Authors:  Candace M Howard; Jagan Valluri; Anthony Alberico; Terrence Julien; Rida Mazagri; Robert Marsh; Hoyt Alastair; Antonio Cortese; Michael Griswold; Wanmei Wang; Krista Denning; Linda Brown; Pier Paolo Claudio
Journal:  Transl Oncol       Date:  2017-02-12       Impact factor: 4.243

2.  Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.

Authors:  Jacob J Mandel; David Cachia; Diane Liu; Charmaine Wilson; Ken Aldape; Greg Fuller; John F de Groot
Journal:  J Neurooncol       Date:  2016-06-07       Impact factor: 4.130

Review 3.  The Multifaceted Metabolism of Glioblastoma.

Authors:  Addison Quinones; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

4.  Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics.

Authors:  S Pedron; H Polishetty; A M Pritchard; B P Mahadik; J N Sarkaria; B A C Harley
Journal:  MRS Commun       Date:  2017-09-12       Impact factor: 2.566

Review 5.  Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.

Authors:  Fang Shen; Yang Zhang; Yu Yao; Wei Hua; Hai-Shi Zhang; Jing-Song Wu; Ping Zhong; Liang-Fu Zhou
Journal:  Neurosurg Rev       Date:  2014-05-01       Impact factor: 3.042

6.  Targeting cancer metabolism.

Authors:  Beverly A Teicher; W Marston Linehan; Lee J Helman
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

7.  Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.

Authors:  Leonard Sunwoo; Seung Hong Choi; Roh-Eul Yoo; Koung Mi Kang; Tae Jin Yun; Tae Min Kim; Se-Hoon Lee; Chul-Kee Park; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Jae-Kyung Won; Sung-Hye Park; Il Han Kim
Journal:  Neuroradiology       Date:  2015-08-01       Impact factor: 2.804

8.  MR Elastography Analysis of Glioma Stiffness and IDH1-Mutation Status.

Authors:  K M Pepin; K P McGee; A Arani; D S Lake; K J Glaser; A Manduca; I F Parney; R L Ehman; J Huston
Journal:  AJNR Am J Neuroradiol       Date:  2017-10-26       Impact factor: 3.825

9.  Association between IDH1/2 mutations and brain glioma grade.

Authors:  Lei Deng; Pengju Xiong; Yunhui Luo; Xiao Bu; Suokai Qian; Wuzhao Zhong; Shunqing Lv
Journal:  Oncol Lett       Date:  2018-08-17       Impact factor: 2.967

10.  Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.

Authors:  Sloane K Tilley; William Y Kim; Rebecca C Fry
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.